Cantor analyst Louise Chen is out with initiation reports assessing Valeant Pharmaceuticals Intl Inc (NYSE:VRX) with more confidence than the rest of the Street’s …
William Blair analyst Tim Lugo reiterates a Market Perform rating on shares of Endo International plc (NASDAQ:ENDP), following the news that the FDA has requested the …
Endo International plc – Ordinary Shares (NASDAQ:ENDP) reported first-quarter 2017 financial results, including: Revenues of $1,038 million, an 8 percent increase compared to …
Canaccord analyst Dewey Steadman is out with a research note on shares of Endo International plc (NASDAQ:ENDP), after the drug giant reported first quarter preliminary revenue …
Endo International plc (NASDAQ:ENDP) is on investors’ radars after the FDA’s Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug …
This afternoon, a joint session of the FDA Drug Safety and Risk Management and the Anesthetic and Analgesic Drug Products Advisory Committees voted …
William Blair analyst Tim Lugo is quite apprehensive on Endo International plc – Ordinary Shares (NASDAQ:ENDP) on the heels of yesterday morning’s review materials …
Top analyst Irina Rivkind Koffler at Mizuho is all the more bullish on Endo International plc – Ordinary Shares (NASDAQ:ENDP) following the subdued …
Endo International plc (NASDAQ:ENDP) announced that one of its operating companies, Par Pharmaceutical has received final approval from the U.S.
In the most recent quarter, billionaire John Paulson, the president and portfolio manager of hedge fund Paulson & Co, made several key changes …
